Narrow search
Showing 1 - 10 of 108
Cover Image
The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry
Banerjee, Tannista; Siebert, Ralph - CESifo - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010734328
Cover Image
Private versus Social Incentives for Pharmaceutical Innovation
Gonzalez, Paula - 2016
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are “follow-on” drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct...
Persistent link: https://www.econbiz.de/10013000227
Cover Image
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector
Gamba, Simona - 2016
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...
Persistent link: https://www.econbiz.de/10012984725
Cover Image
Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008
Varol, Nebibe - 2014
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10013068052
Cover Image
The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry
Banerjee, Tannista; Siebert, Ralph - 2021
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10013315639
Cover Image
Pharmaceutical Patents : Incentives for R&D or Marketing?
Brekke, Kurt Richard; Straume, Odd Rune - 2021
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry. Within a fairly general model framework,...
Persistent link: https://www.econbiz.de/10013316463
Cover Image
Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale
Varol, Nebibe; Costa-i-Font, Joan; McGuire, Alistair - CESifo - 2011
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the probability of launch, controlling for competition,...
Persistent link: https://www.econbiz.de/10009020788
Cover Image
Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008
Varol, Nebibe; Costa-i-Font, Joan; McGuire, Alistair - CESifo - 2011
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10009021239
Cover Image
Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - CESifo - 2010
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using … a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on …
Persistent link: https://www.econbiz.de/10008799730
Cover Image
Powering Up Developing Countries through Integration?
Auriol, Emmanuelle; Biancini, Sara - CESifo - 2012
Power market integration is analyzed in a two countries model with nationally regulated firms and costly public funds. If generation costs between the two countries are too similar negative business-stealing outweighs efficiency gains so that following integration welfare decreases in both...
Persistent link: https://www.econbiz.de/10010556079